Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group - PubMed (original) (raw)
Clinical Trial
. 1997 Apr;39(4):499-508.
doi: 10.1093/jac/39.4.499.
Affiliations
- PMID: 9145823
- DOI: 10.1093/jac/39.4.499
Clinical Trial
Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group
S Ragnar Norrby. J Antimicrob Chemother. 1997 Apr.
Abstract
Community-aquired pneumonia caused by atypical bacteria or viruses was studied in a double-blind trial comparing fleroxacin 400 mg od and doxycycline 100 mg bd for 10 days. The aetiology was confirmed in 258 of 411 cases (66%), of which 133 were caused by Mycoplasma spp., Chlamydia spp. or Legionella spp.; 30 patients had viral infection, nine had pneumococcal or Haemophilus influenzae infection and 93 had mixed aetiology. In intention-to-treat analyses clinical response rates in fleroxacin-treated patients were 86% (157/182) and 75% (137/182) 2-8 days and 3-5 weeks after therapy, respectively. Corresponding results with doxycycline were 93% (177/191) and 85% (162/190), respectively. Differences between treatments seemed to be due to the lower activity of fleroxacin compared with doxycycline against mycoplasma and pneumococci. Drug-related adverse events were reported in 39% of 204 fleroxacin patients and in 34% of 207 doxycycline patients. The null hypothesis that fleroxacin was <15% inferior to doxycycline was accepted at early follow-up but rejected at later review.
Similar articles
- Treatment for community acquired pneumonia: more support for doxycycline.
Ditmanson L, Apgar D. Ditmanson L, et al. Arch Intern Med. 1999 Aug 9-23;159(15):1814-5. doi: 10.1001/archinte.159.15.1814. Arch Intern Med. 1999. PMID: 10448791 No abstract available. - Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia.
Teh B, Grayson ML, Johnson PD, Charles PG. Teh B, et al. Clin Microbiol Infect. 2012 Apr;18(4):E71-3. doi: 10.1111/j.1469-0691.2011.03759.x. Epub 2012 Jan 27. Clin Microbiol Infect. 2012. PMID: 22284533 - Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts.
Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE; Alkmaar study group; Ovidius study group. Raeven VM, et al. BMC Infect Dis. 2016 Jun 17;16:299. doi: 10.1186/s12879-016-1641-9. BMC Infect Dis. 2016. PMID: 27317257 Free PMC article. - 13--Antibiotic therapy of community-acquired pneumonia (CAP) caused by atypical agents.
Roig J, Casal J, Gispert P, Gea E. Roig J, et al. Med Mal Infect. 2006 Nov-Dec;36(11-12):680-9. doi: 10.1016/j.medmal.2006.07.020. Epub 2006 Nov 13. Med Mal Infect. 2006. PMID: 17095177 Review.
Cited by
- Global Perspective of Legionella Infection in Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Observational Studies.
Graham FF, Finn N, White P, Hales S, Baker MG. Graham FF, et al. Int J Environ Res Public Health. 2022 Feb 8;19(3):1907. doi: 10.3390/ijerph19031907. Int J Environ Res Public Health. 2022. PMID: 35162928 Free PMC article. Review. - Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class.
Bidell MR, Pai MAP, Lodise TP. Bidell MR, et al. Antibiotics (Basel). 2020 Dec 14;9(12):905. doi: 10.3390/antibiotics9120905. Antibiotics (Basel). 2020. PMID: 33327437 Free PMC article. Review. - Chlamydia psittaci (psittacosis) as a cause of community-acquired pneumonia: a systematic review and meta-analysis.
Hogerwerf L, DE Gier B, Baan B, VAN DER Hoek W. Hogerwerf L, et al. Epidemiol Infect. 2017 Nov;145(15):3096-3105. doi: 10.1017/S0950268817002060. Epub 2017 Sep 26. Epidemiol Infect. 2017. PMID: 28946931 Free PMC article. Review. - High-Throughput Intracellular Antimicrobial Susceptibility Testing of Legionella pneumophila.
Chiaraviglio L, Kirby JE. Chiaraviglio L, et al. Antimicrob Agents Chemother. 2015 Dec;59(12):7517-29. doi: 10.1128/AAC.01248-15. Epub 2015 Sep 21. Antimicrob Agents Chemother. 2015. PMID: 26392509 Free PMC article. - Antibiotics for community-acquired pneumonia in adult outpatients.
Pakhale S, Mulpuru S, Verheij TJ, Kochen MM, Rohde GG, Bjerre LM. Pakhale S, et al. Cochrane Database Syst Rev. 2014 Oct 9;2014(10):CD002109. doi: 10.1002/14651858.CD002109.pub4. Cochrane Database Syst Rev. 2014. PMID: 25300166 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous